A new drug that has passed safety tests in adults is likely to be effective against the aggressive childhood cancer neuroblastoma.
Cancer Research UK and the US National Cancer Institute, are uniting to define a new era in cancer research and discovery.
Protective cells in the lungs of ex-smokers could explain why quitting smoking reduces the risk of developing lung cancer.
Three studies from Cancer Research UK’s TRACERx project reveal early signs that lung cancer may spread and become untreatable.
Three research teams have been awarded a combined total of £18 million to break new ground in the way we understand brain tumours and how they develop.
Mutations that cause oesophageal adenocarcinoma have been mapped in unprecedented detail – more than half could be targeted by drugs currently in trials.
This collaboration will help develop a ‘rule book’ to guide precision combination immunotherapies and to speed up the development of new lung cancer treatments.
Scientists have discovered that cancerous cells in an aggressive type of childhood brain tumour work together to infiltrate the brain.